en

PRODUCT DETAIL

Rystiggo 140 mg/ml injekčný roztok

Code 5244E
MA number EU/1/23/1780/001
Product Form: sol inj 1x2 ml/280 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AG ?
L04AG16 Rozanolixizumab
Shelf life: 24
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 05.01.2024
Validity: 05.01.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 17.01.2024
eu-flag.png sk-flag.png